Jane Zhao

Title: The Innovative Contributions of Jane Zhao

Introduction

Jane Zhao is a prominent inventor based in Austin, Texas, known for her groundbreaking work in the field of cancer treatment. With a focus on innovative therapies, she has made significant strides in the medical community, particularly in the treatment of liver cancer.

Latest Patents

Jane Zhao holds a patent for a method titled "Sorafenib-microRNA combination therapy for liver cancer." This innovative approach involves administering a synthetic oligonucleotide to a subject with liver cancer, which comprises a sequence that is at least 80% identical to specific sequences. Additionally, the method includes administering sorafenib, with a molar ratio of sorafenib to oligonucleotide that ranges from about 10 to 2000, aiming to achieve a synergistic effect in treatment.

Career Highlights

Throughout her career, Jane has been associated with Mirna Therapeutics, Inc., where she has contributed her expertise in developing novel therapeutic strategies. Her work has been instrumental in advancing the understanding and treatment of liver cancer, showcasing her dedication to improving patient outcomes.

Collaborations

Jane collaborates with various professionals in her field, including her coworker Andreas Bader, to further enhance the impact of her research and innovations.

Conclusion

Jane Zhao's contributions to cancer treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work continues to inspire and pave the way for future developments in the field.